Purdue Pharma

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Purdue Pharma sits in the top decile of US sponsors by registered trial count (#351 of 15,742 sponsors by registered trial count).

54 total trials none currently recruiting 42 completed top decile by trial count

Purdue Pharma: 54 sponsored US clinical trials, none currently recruiting.

Purdue Pharma sponsors 54 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 42 completed. 31 of these trials are in Phase 3-4 (later-stage) and 22 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Low Back Pain, with 3 trials.

Top-decile sponsor footprint

Purdue Pharma ranks in the top decile of sponsors by registered trial count (#351 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 34/100

42 of 54 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (77.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

54 total, page 2 of 2

COMPLETED Phase 3

The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain.

NCT00315445
COMPLETED Phase 3

The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain.

NCT00315874
COMPLETED Phase 3

The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.

NCT00315848
COMPLETED Phase 2

Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Surgery.

NCT00315835
← Previous Page 2 of 2

Phase Distribution

PhaseTrial count
Phase 1 15
Phase 2 7
Phase 3 28
Phase 4 3

Therapeutic Areas

Low Back Pain 3
Healthy 3
Osteoarthritis 2
ECG Effects 1
Chronic Nonmalignant and Nonneuropathic Pain 1
Opioid Analgesia 1
Pain 1
Healthy Volunteers 1

How the Purdue Pharma archive is shaped

54 indexed studies, none listed as recruiting (0% open); 42 completed (78%).

Phase mix: 31 late (III/IV) vs 22 early (I/II) (balanced across stages).

Top condition: Low Back Pain (3 trials), 7 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Purdue Pharma: archived-pipeline peers nationwide

Peers matched on 54 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Purdue Pharma sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0204060 0%10%20%30% Total trials Recruiting share Purdue PharmaAdventHealth Translational Research InstituteAuburn UniversityBrooke Army Medical CenterCorcept Therapeutics10xBio22nd Century Group23andMe3-C Institute for Social Development
Purdue Pharma sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Purdue Pharma sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 54 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Purdue Pharma page

54 registered trials is a research-attention snapshot, not an endorsement of Purdue Pharma or any single study.

  • None of Purdue Pharma's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Low Back Pain is the condition Purdue Pharma studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Low Back Pain trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Purdue Pharma pipeline card: 54 registered trials from official public datasets.Report a data error.